Status:
COMPLETED
Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
HIV
Smoking Cessation
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The proposed study will use a factorial design to evaluate the most promising and accessible behavioral and pharmacologic treatments aimed at achieving maximal efficacy for smoking cessation among peo...
Detailed Description
The proposed study will use a factorial design to evaluate the most promising and accessible behavioral and pharmacologic treatments aimed at achieving maximal efficacy for smoking cessation among peo...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Chart diagnosis of HIV at recruitment clinic.
- Age 18 years and older
- Currently self-report smoking approximately 1 cigarette per day.
- Motivation to quit (score 6-8 on the Abrams and Briener Readiness to Quit Ladder)
- Able to read and speak English or Swahili
- Willingness and ability to provide informed consent to participate
- Exclusion Criteria:
- Has a history of seizure disorder or bulimia nervosa
- Recent use of Bupropion (by participant report in the past 3 months)
- Previous allergic reaction/hypersensitivity to Bupropion (by participant report ever in lifetime)
- Pregnant, nursing, or becoming pregnant during the study (pregnancy test)
- Current use of any medication that would interfere with the protocol in the opinion of a medically accountable Physician
- Known plans to re-locate or travel away from the study site for more than two consecutive months during the study period.
- Expected survival of less than 6 months
- Meets criteria for dementia by scoring below 10 on the Hopkins HIV Dementia Scale.
- The study physician believes that the individual is not medially stable enough to participate in the study. This exclusion will be based on a review of the individual's past medical history and current medical status.
- Based on screening, not meeting criteria for moderate or severe substance disorder as established by the MINI International Neuropsychiatric Interview.
Exclusion
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03342027
Start Date
August 1 2020
End Date
July 25 2023
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for International Health, Education, and Biosecurity (CIHEB)
Kilimani, Nairobi County, Kenya